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Background: Nosocomial infections are an important cause of
orbidity and mortality in ICU patients. Fungal infections espe-
ially Candidemia are commonnosocomial bloodstream infections.
his study is conducted to assess the clinical proﬁle, risk factors and
utcome of patients with Candidemia.
Methods: This is a prospective study. Study period: 6 months
romAugust 2011 to January 2012. Patientswith blood culture pos-
tive forCandidawere included in the studyand their clinical proﬁle
nd outcomes were studied.
Results: Total of 23 patients were included in this study. Aver-
ge age of the patients in the study was 47 years with 48% males.
he following risk factors for Candidemia were found to be com-
on in our study: 17 patients (74%) had duration of ICU stay >7
ays; 23 patients (100%) were on broad spectrum antibiotics for
5 days; 17 patients (74%) had central venous catheters in situ at
he time of development of Candidemia; 20 patients (87%) were
n mechanical ventilation; 18 patients (78%) were in severe sepsis.
verage duration of ICU stay was 16.3 days. Most commonly used
ntibiotic was Piperacillin-Tazobactum followed by Cefoperazone-
ulbactum. Average duration of broad spectrum antibiotic use was
2.6 days prior to development of Candidemia. Central Venous
atheters were present for an average duration of 10 days prior
o the development of Candidemia. 20 patients (87%) who devel-
ped Candidemia were on mechanical ventilation with an average
uration of 8.4 days. The most common species grown in culture
as Candida tropicalis (45%). Candida albicanswas associatedwith
nly 11% of cases. All of the Candida isolates were sensitive to Flu-
onazole. 57% of the patients received treatment. Mortality rate in
ur study was 61% (14 patients).
Conclusion: Candidemia is to be considered as an important
ause of morbidity and mortality in ICU patients especially those
ith prolonged ICU stay, broad spectrum antibiotic use, pres-
nce of Central venous catheters, mechanical ventilation and those
n severe sepsis. Non-Albicans species were more common than
lbicans species. However all of the isolates were sensitive to Flu-
onazole. Candidemia is associated with high mortality rates in the
CUs.
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Background: Malaysia is one of the regions where the num-
ber of people infected with HIV/AIDS is among one of the fastest
growing in the world. Since the beginning of the HIV pandemic
in Malaysia, Penicilliosis has become an important opportunistic
infection. This study was conducted to describe the clinical presen-
tation and outcomes of patients with advanced HIV presented with
Penicillium marneffei infections.
Methods: Retrospective review of all patients with retroviral
disease (RVD) admittedwith Penicilliummarneffei infections during
January to December 2008 in Hospital Sungai Buloh, Malaysia.
Results: A total of twenty-three RVD patients with P marneffei
infections were identiﬁed from January to December 2008. Their
median CD4 cell count when P marneffei infection was diagnosed
was 10.0 cells/mm2 (IQR, 1.0–55.0 cells/mm2). The characteris-
tic umbilicated papular skin lesion with central necrosis was the
commonest presenting features (82.6%) followed by fever (78.3%),
malaise, anaemia and hepatomegaly (73.9%). Clinical response was
observed in twenty patients treatedwith systemic antifungal treat-
ment. Three patients (13%) died due to late presentation and late
diagnosis.
Conclusion: Penicillium marneffei infection is endemic and has
been recognized as an AIDS deﬁning illness in Malaysia. Timely
diagnosis and early appropriate antifungal therapy is vital to sig-
niﬁcantly decrease the mortality rate
http://dx.doi.org/10.1016/j.ijid.2012.05.374
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The rate of Pneumocystis jirovecii pneumonia in Iranian HIV
positive patients with pulmonary inﬁltrates
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Moghadam1, H. Emadikochak3
1 Tarbiat Modares University, Tehran, Iran, Islamic Republic of
2 Mycobacteriology Research Center, Tehran, Iran, Islamic Republic of
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Background: Pneumocystis pneumonia (PcP) which is caused
by Pneumocystis jirovecii is an important agent of hospitalization
and death in immunocompromised patients especially amongHIV-
infected persons. Here, we reported the ﬁrst in depth molecular
analysis of P. jirovecii epidemy among HIV-infected patients.
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discharge was subjected to wet mount examination, gram stain-
ing and for culture. Data were collected through interviews with15th ICID Abstracts / International Journa
Methods:Twomitochondrial large-subunit rRNA(mtLSUrRNA)
nd dihydropteroate synthase (DHPS) genes were investigated
singnestedPolymeraseChainReaction (PCR) andRestrictionFrag-
ent Length Polymorphism (PCR-RFLP). Respiratory specimens
ollected from126 IranianHIV-positive patients referred to Iranian
IV/AIDSResearchCenter andNationalResearch Instituteof Tuber-
ulosis and Lung Disease (during August 2010 to March 2011). The
atients with cough, fever, pneumothorax, dyspnea and/or abnor-
al chest X-ray were introduced to this study.
Results:One hundred and twelve patientsweremale (89%). The
ean age of patients was 35.12±9.75 years and the median was
3 years. Median of CD4 T cell count of patients was 93 cells/l.
hirty nine (31%) of patients were hospitalized.Twenty four sam-
les (19.1%) were positive for M. tuberculosis. In spite of getting
rophylaxis for PcP and HARRT treatment, the DNA of P. jirovecii
ere detected in 15 samples (11.9%). Just one patient (0.8%) was
o-infected with both P. jirovecii and M. tuberculosis. In this cate-
ory of patients no othermicroorganismswere detected by culture.
he causes of pneumonia in the remaining 87 patients (69%) were
he other bacterial and viral agents.
The mortality rate of disease was 26.6% in these patients due to
cP. oneof the isolate (6.6%)had shownmutation in55codonwhich
re associatedwith resistance to sulfa/sulfondrugs. The sequencing
esults of mt LSU rRNA gene showed that the genetic patterns of
ranian isolates were similar to Indian and Spanish isolates (99%
dentity).
Conclusion: The study showed the rate of disease in Iranian
IV-infected patients is similar to Asian countries and some area in
frica. Sincewecouldﬁnd just one isolatewithmutation associated
ith drug resistance in DHPS gene, it is very difﬁcult to explain
he high rate of disease. The similarity of Iranian isolates to Indian
solates is probably due to close geographical region.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.375
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n vitro activities of caspofungin and ketoconazole against Ira-
ian isolates of Candida albicans
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slamic Republic ofBackground: Since 1980, studies have shown that systemic
nd saprophyte Candidainfections have noticeably increased and
. albicansis the dominant organismof Candidainfections. In recentfectious Diseases 16S (2012) e317–e473 e327
years, candidiasis, particularly the systemic one has become a fun-
damental problem in medicine The main causes of this increase
are gastrointestinal and heart surgery, immune system deﬁciency,
use of antibiotics and the catheters, bone marrow transplanta-
tion, chemotherapy in cancer patients and drug addiction .Today,
systemic candidiasis is the forth or ﬁfth cause of septicemia.
Amphotericin B has been used as the main treatment for candidia-
sis in the past decadeswhile the poisonous effects of it have limited
its usage. This poisonous effect is proved about voriconazol as well.
Thus, the need for serious treatment has led to new approaches to
use caspofungin and other azole drugs such as voriconazol.
Methods: A total of 108 clinical C. albicansstrains associated
with infections in high risk patients were included in this study.
These isolates were differentiated by CHROM agar and veriﬁed
by API 20 AUX. In vitro susceptibilities to caspofungin and keto-
conazole were performed in accordance with broth microdilution
method described in Clinical Laboratory Standards Institute.
Results: Results showed that among examined 108 C. albi-
cansstrains, 87% were inhibited by caspofungin, 70.4% were
susceptible to ketoconazole and 29.6% were susceptible depen-
dent upon dose range. The results revealed that caspofungin was
more active than ketoconazole against tested C. albicansstrains
(P <0.005). Although the MIC90 of caspofungin and ketoconazole
were as high as 4g and 16g/ml the MIC50 of both drugs were
similar (2g/ml). It seems that both antifungal agents are relatively
active against IranianC. albicans strains.
Conclusion: C. albicans strains showed susceptibility to caspo-
funginhigher thanketoconazole (P <0.005). 100%C.albicans Strains
associated with cancer and blood malignancy patients were sus-
ceptible to caspofungin and C.albicans associated with patients
suffering from diabetes revealed 94.4%. susceptibility. However, in
C.albicans strains associated with HIV patients little susceptibility
was observed to caspofungin.
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Background: Candidiasis is the most common gynecologic
problem for which women seek treatment. They show acute or
chronic courses and different disease patterns which can strongly
affect the quality of life of the women who are concerned. The pur-
pose of this study is to evaluate the inﬂuence of oral contraceptive
(OC) use on women’s candidiasis. in referent to medical and health
centers in Hamadan city, Iran.
Methods: Eighty women aged 20 to 45 years were included
in the study. They were divided into two groups, oral contracep-
tive users and non-users. A vaginal sample from each subject was
cultured to investigate the presence of Candida species. Vaginalwomen in the clinics in the health centers. Data processing and
statistical analysis were performed using SPSS 10.0.
